ArticlePopulation health metrics2013
Descriptive epidemiology of chronic liver disease in northeastern Italy: an analysis of multiple causes of death.
Article in Population health metrics, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed.
- The role of an integrated referral program for patients with liver disease: A network between hub and spoke centers.United European gastroenterology journal · 2024Article
- Analysis of Multiple Causes of Death: A Review of Methods and Practices.Epidemiology (Cambridge, Mass.) · 2023Review
- Changes in the etiology of chronic liver disease by referral to a FibroScan center: Increasing prevalence of the nonalcoholic fatty liver disease.Hepatology forum · 2023Article
- Changes in liver-related mortality by etiology and sequelae: underlying versus multiple causes of death.Population health metrics · 2021Article
- Occupational exposure to vinyl chloride and liver diseases.World journal of gastroenterology · 2019Review
- The burden of chronic diseases and cost-of-care in subjects with HIV infection in a Health District of Northern Italy over a 12-year period compared to that of the general population.BMC public health · 2016Article
- The Role of Ischemia Modified Albumin as a Biomarker in Patients with Chronic Liver Disease.Journal of clinical and diagnostic research : JCDR · 2016Article
- Mapping the cause-specific premature mortality reveals large between-districts disparity in Belgium, 2003-2009.Archives of public health = Archives belges de sante publique · 2015Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe analysis of multiple causes of death data has been applied in the United States to examine the population burden of chronic liver disease (CLD) and to assess time trends of alcohol-related and hepatitis C virus (HCV)-related CLD mortality. The aim of this study was to assess the mortality for CLD by etiology in the Veneto Region (northeastern Italy).
methodsUsing the 2008-2010 regional archive of mortality, all causes registered on death certificates were extracted and different descriptive epidemiological measures were computed for HCV-related, alcohol-related, and overall CLD-related mortality.
resultsThe crude mortality rate of all CLD was close to 40 per 100,000 residents. In middle ages (35 to 74 years) CLD was mentioned in about 10% and 6% of all deaths in males and females, respectively. Etiology was unspecified in about half of CLD deaths. In females and males, respectively, HCV was mentioned in 44% and 21% and alcohol in 11% and 26% of overall CLD deaths. A bimodal distribution with age was observed for HCV-related proportional mortality among females, reflecting the available seroprevalence data.
conclusionsMultiple causes of death analyses can provide useful insights into the burden of CLD mortality according to etiology among different population subgroups.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.